-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TMS-007 in Acute Ischemic Stroke
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TMS-007 in Acute Ischemic StrokeDrug Details:TMS-007 (Stachybotrys microspora triprenyl phenol-7) is under development for the treatment...
-
Product Insights
TM Invest Niksic Solar PV Park
TM Invest Niksic Solar PV Park profile includes core details such as plant name, technology, capacity, status, plant proponents (owners, developers etc.), owner stakes etc as well as key operational data including generation, year online, decommissioning year, capital expenditure etc. Details on project specific contacts along with relevant news, deals and contracts are also provided through the plant profile. This is an on-demand report that will be delivered upon request. The report will be delivered within 1 business day of...
-
Product Insights
TMS Const – Hesperia Residential Apartment – California
Equip yourself with the essential tools needed to make informed and profitable decisions with our TMS Const - Hesperia Residential Apartment - California report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
TM RE – Plantation Midtown Square – Florida
Equip yourself with the essential tools needed to make informed and profitable decisions with our TM RE - Plantation Midtown Square - Florida report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into the...
-
Product Insights
TM RE – Sunset Cliffs Residential Complex – Valencia
Equip yourself with the essential tools needed to make informed and profitable decisions with our TM RE - Sunset Cliffs Residential Complex - Valencia report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
TMS Grp – Quang Binh Resort Complex – Quang Binh
Equip yourself with the essential tools needed to make informed and profitable decisions with our TMS Grp - Quang Binh Resort Complex - Quang Binh report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
TM Montante – Lancaster Square at Gates Circle – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our TM Montante - Lancaster Square at Gates Circle - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
TMS Grp – Lang Son Resort and Sports Complex – Lang Son
Equip yourself with the essential tools needed to make informed and profitable decisions with our TMS Grp - Lang Son Resort and Sports Complex - Lang Son report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
TMS Grp – Mui Ne Wonder World Urban Resort Marine Complex – Binh Thuan
Equip yourself with the essential tools needed to make informed and profitable decisions with our TMS Grp - Mui Ne Wonder World Urban Resort Marine Complex - Binh Thuan report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the...
-
Product Insights
RXR Realty/ Titan Machinery – RXR/TM City Mixed-Use Office Tower – New York
Equip yourself with the essential tools needed to make informed and profitable decisions with our RXR Realty/ Titan Machinery - RXR/TM City Mixed-Use Office Tower - New York report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Sector Analysis
NewIceland Insurance Industry – Key Trends and Opportunities to 2027
Iceland Insurance Industry Report Overview The total gross written premium (GWP) in the Iceland insurance industry was ISK86.8 billion in 2022 and is expected to record a CAGR of more than 6% during 2023-2027. Iceland's economy is mainly driven by tourism and exports, which contributed to real GDP growth of 6.4% in 2022. To foster growth in the economy, regulatory reforms should be implemented, which will ease market access for new firms, while the education system should be expanded to...
-
Company Profile
![]()
EDAP TMS SA – Company Profile
EDAP TMS SA (EDAP) is a medical device company that carries out the development, production, and distribution of minimally invasive medical devices for various pathologies and treatment of urological diseases and other indications using ultrasound technology. It offers high intensity focused ultrasound (HIFU) devices in prostate cancer and extracorporeal shock-wave lithotripters (ESWL) for the treatment of urinary tract stones. The company products include ablatherm fusion, focal one, sonolith i-move, sonolith i-sys and laserlith i-dust, among others. It offers products to...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CD-388 in Pandemic Influenza
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Pandemic InfluenzaDrug Details:CD-388 is under development for the treatment and prevention of influenzavirus A,...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CD-388 in Influenzavirus A Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Influenzavirus A Infections Drug Details:CD-388 is under development for the treatment and prevention of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CD-388 in Influenzavirus B Infections
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Influenzavirus B Infections Drug Details:CD-388 is under development for the treatment and prevention of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – CD-388 in Seasonal Influenza
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CD-388 in Seasonal Influenza Drug Details:CD-388 is under development for the treatment and prevention of influenzavirus...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Acloproxalap in Chronic Cough
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Acloproxalap in Chronic CoughDrug Details:Acloproxalap (ADX-629) is under development for the treatment of non-alcoholic steatohepatitis (NASH),...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMS-986218 in Melanoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.BMS-986218 in MelanomaDrug Details:BMS-986218 is under development for the treatment of advanced solid tumors including prostate...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – 212Pb-DOTAM-GRPR1 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. 212Pb-DOTAM-GRPR1 in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Drug...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Vudalimab in Thymic Carcinoma
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Vudalimab in Thymic Carcinoma Drug Details: XmAb-717 is under development for the treatment of cervical...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.